Konrad Dobschuetz is a recognised global HealthTech leader. He is focused on the commercial adoption of impactful innovations fostering positive patient outcomes. In his he zooms in on emerging tech such as AI in diagnostics, pathway management and risk prediction. In his former role as National Director in the NHS Innovation Accelerator, its solutions reached over 3 million patients by the end of 2023. Konrad also worked for Novartis and Pfizer, driving large scale digital transformation initiatives across a range of markets and implementing innovations for example to identify future patient needs using AI prediction.